Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03285282
Other study ID # 123/2017
Secondary ID
Status Recruiting
Phase Early Phase 1
First received September 14, 2017
Last updated September 14, 2017
Start date May 8, 2017
Est. completion date November 2017

Study information

Verified date September 2017
Source Ain Shams University
Contact Mona Ammar, MD
Phone 01006236620
Email Mona_3mmar@Hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Several regional anesthesia have been shown to improve postoperative outcomes in many studies. The transversus abdominis plane (TAP) block provides anesthesia to the abdominal wall by introducing local anesthetic to the anterior rami of the spinal nerve roots. This work evaluates the analgesic effects gained after performing thoracolumbar interfacial plane block (analogous to the TAP block but intended for the back) which targets the sensory component of the dorsal rami of the thoracolumbar nerves in patients undergoing back surgeries.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date November 2017
Est. primary completion date October 2017
Accepts healthy volunteers No
Gender All
Age group 21 Years to 60 Years
Eligibility Inclusion Criteria:

- patients with ASA 1 or 2 aged between 21years old up to 60 years old of both sex scheduled of back surgery

Exclusion Criteria:

- Exclusion criteria will be patients refusal or inability to give an informed consent , history of relevant allergy to any of the drugs used in the procedure , previous lumbar spine surgery or back surgery with planed spinal fixation.

Study Design


Related Conditions & MeSH terms

  • Postoperative Analgesia After Disc Surgery

Intervention

Procedure:
Thoracolumber interfascial plane block
Thoracolumber interfascial plane block versus placebo

Locations

Country Name City State
Egypt Faculty of medicine Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Score 24 hrs postoperative
Secondary Total morphine consumption 24 hrs postoperative